Integration of Breast and Lung Cancer Screening Programs Recommended by Experts

 A recent analysis led by researchers at Thomas Jefferson University in Philadelphia advocates integrating breast and lung cancer screening programs to enhance disease monitoring. Published on July 3 in the Journal of the American College of Radiology, the study addresses challenges in screening adherence and highlights opportunities for efficient, coordinated care.

Breast cancer screening via mammography, despite its proven benefits, has completion rates as low as 55%, with socioeconomically disadvantaged groups particularly affected. The research team emphasizes the unique health care needs of women eligible for lung cancer screening due to their increased cancer risk.

The study analyzed patients participating in lung cancer screening from 2018 to 2025 at an academic medical center. Among nearly 4,400 participants, approximately 2,100 women were also eligible for breast cancer screening. Results indicated that 54% had undergone mammography within one year of low-dose CT lung screening, and 67% within two years—figures notably below the national estimate of nearly 80%.

Key findings revealed that higher smoking pack-years and a personal history of cancer corresponded with delays in breast cancer screening, highlighting a critical gap in preventive care for high-risk individuals. Notably, Black women were less likely to be overdue for breast screenings compared to their white counterparts.

The study also observed differing impacts of chronic obstructive pulmonary disease (COPD) on screening adherence. Patients with EHR-documented COPD were less likely to miss breast cancer screenings, possibly due to greater health care engagement. In contrast, those reporting COPD independently were more often overdue.

Lead author Dr. Meghan Maceyko and colleagues propose integrating navigation and scheduling within lung cancer screening workflows to foster a reciprocal increase in both screening modalities. This could reduce disparities and enhance early breast cancer detection by tailoring approaches for high-risk women.

“To maximize the impact of cancer screening programs, a coordinated strategy that integrates navigation and scheduling into screening workflows is essential,” Maceyko stated. “This approach may serve to bridge gaps in screening completion and improve outcomes for vulnerable populations.”

This analysis underscores the potential benefits of a unified framework for cancer screening, emphasizing that enhanced cooperation among screening programs can significantly boost preventive health measures.